chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Confusional state, Cough, Fatigue, Nausea, Pain
Clinical narrative: Confusion; Cough; nausea; fatigue; ache; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (Confusion), PAIN (ache), COUGH (Cough), NAUSEA (nausea) and FATIGUE (fatigue) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced PAIN (ache), NAUSEA (nausea) and FATIGUE (fatigue). On 02-Mar-2021, the patient experienced CONFUSIONAL STATE (Confusion) and COUGH (Cough). On 25-Feb-2021, PAIN (ache), NAUSEA (nausea) and FATIGUE (fatigue) had resolved. At the time of the report, CONFUSIONAL STATE (Confusion) and COUGH (Cough) outcome was unknown.            No relevant concomitant medications were reported. Treatment details were not provided.      This case was linked to MOD21-043334 (Patient Link).
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Itchiness; Extreme rash; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchiness) and RASH (Extreme rash) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 011620A) for COVID-19 vaccination.     Concomitant products included AMLODIPINE and MIRTAZAPINE for an unknown indication.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced PRURITUS (Itchiness) and RASH (Extreme rash). The patient was treated with PREDNISONE at a dose of 1 dosage form; CHLORPHENAMINE MALEATE (ALLERFIN) at a dose of 1 dosage form and CORTISONE at a dose of 1 dosage form. At the time of the report, PRURITUS (Itchiness) and RASH (Extreme rash) had not resolved.            Treatment: prednisone, allerfin, eucerin cream, cortisone 10 cream   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Non significant follow up- No new information was provided.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: sore arm; slight fever that was short lived; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and PYREXIA (slight fever that was short lived) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and PYREXIA (slight fever that was short lived). At the time of the report, PAIN IN EXTREMITY (sore arm) and PYREXIA (slight fever that was short lived) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.  No treatment information was not provided.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Itching; Redness at injection site; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PAIN (Soreness) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itching), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PAIN (Soreness). At the time of the report, VACCINATION SITE PRURITUS (Itching), VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PAIN (Soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.   Reporter did not allow further contact
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Facial pain, Swelling face
Clinical narrative: Face Swelling; Face hurting on left siide, Face soreness on left side; Shoulder pain; This spontaneous case was reported by a consumer and describes the occurrence of FACIAL PAIN (Face hurting on left siide, Face soreness on left side), SWELLING FACE (Face Swelling) and ARTHRALGIA (Shoulder pain) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced ARTHRALGIA (Shoulder pain). On 03-Feb-2021, the patient experienced FACIAL PAIN (Face hurting on left siide, Face soreness on left side). On 06-Feb-2021, the patient experienced SWELLING FACE (Face Swelling). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of 1 dosage form. On 13-Feb-2021, SWELLING FACE (Face Swelling) had resolved. At the time of the report, FACIAL PAIN (Face hurting on left siide, Face soreness on left side) was resolving and ARTHRALGIA (Shoulder pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was unknown by the reporter.  Patient took Tylenol and applied ice on her shoulder.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Dyspnoea, Fatigue, Muscular weakness, Pain
Clinical narrative: hit by a truck; neuromuscular symptoms; tingling; burning; shortness of breath; tachycardia; very fatigued; This spontaneous case was reported by a physician and describes the occurrence of PAIN (hit by a truck), MUSCULAR WEAKNESS (neuromuscular symptoms), PARAESTHESIA (tingling), BURNING SENSATION (burning) and DYSPNOEA (shortness of breath) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (hit by a truck), MUSCULAR WEAKNESS (neuromuscular symptoms), PARAESTHESIA (tingling), BURNING SENSATION (burning), DYSPNOEA (shortness of breath), TACHYCARDIA (tachycardia) and FATIGUE (very fatigued). At the time of the report, PAIN (hit by a truck), MUSCULAR WEAKNESS (neuromuscular symptoms), PARAESTHESIA (tingling), BURNING SENSATION (burning), DYSPNOEA (shortness of breath), TACHYCARDIA (tachycardia) and FATIGUE (very fatigued) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  No treatment information was provided.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Tachycardia
Clinical narrative: hit by a truck; neuromuscular symptoms; tingling; burning; shortness of breath; tachycardia; very fatigued; This spontaneous case was reported by a physician and describes the occurrence of PAIN (hit by a truck), MUSCULAR WEAKNESS (neuromuscular symptoms), PARAESTHESIA (tingling), BURNING SENSATION (burning) and DYSPNOEA (shortness of breath) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (hit by a truck), MUSCULAR WEAKNESS (neuromuscular symptoms), PARAESTHESIA (tingling), BURNING SENSATION (burning), DYSPNOEA (shortness of breath), TACHYCARDIA (tachycardia) and FATIGUE (very fatigued). At the time of the report, PAIN (hit by a truck), MUSCULAR WEAKNESS (neuromuscular symptoms), PARAESTHESIA (tingling), BURNING SENSATION (burning), DYSPNOEA (shortness of breath), TACHYCARDIA (tachycardia) and FATIGUE (very fatigued) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  No treatment information was provided.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Dry mouth, Dysgeusia, Pyrexia
Clinical narrative: Eats half of what he used to eat on the plate; Mouth gets very dry at night; Fever; Metallic taste in mouth; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Eats half of what he used to eat on the plate), DYSGEUSIA (Metallic taste in mouth), DRY MOUTH (Mouth gets very dry at night) and PYREXIA (Fever) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced DYSGEUSIA (Metallic taste in mouth) and PYREXIA (Fever). On an unknown date, the patient experienced DECREASED APPETITE (Eats half of what he used to eat on the plate) and DRY MOUTH (Mouth gets very dry at night). At the time of the report, DECREASED APPETITE (Eats half of what he used to eat on the plate), DRY MOUTH (Mouth gets very dry at night) and PYREXIA (Fever) outcome was unknown and DYSGEUSIA (Metallic taste in mouth) had not resolved.            No concomitant medications were reported. No treatments were reported.   This case was linked to MOD-2021-032335 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Additional information provided:New events added and events outcome updated; Sender's Comments:  MOD-2021-032335:Same reporter/Different patient
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Off label use, Product administered to patient of inappropriate age
Clinical narrative: Vaccinated a 16 year old; Off-Label use; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccinated a 16 year old) and OFF LABEL USE (Off-Label use) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccinated a 16 year old) and OFF LABEL USE (Off-Label use). On 02-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccinated a 16 year old) and OFF LABEL USE (Off-Label use) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  No adverse events were reported after vaccine administration. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 31-Mar-2021: The patient's race, ethnicity, pregnancy information updated and event off label use was added.; Sender's Comments: This report refers to a case of product administered to patient of inappropriate age (16 year old female) for mRNA-1273 (lot number 010A21A) with no associated AEs reported.
Sex: M
Vaccine: COVID19
Symptoms: Discomfort, Fatigue, Insomnia
Clinical narrative: mild discomfort; insomnia; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (mild discomfort), INSOMNIA (insomnia) and FATIGUE (fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DISCOMFORT (mild discomfort), INSOMNIA (insomnia) and FATIGUE (fatigue). At the time of the report, DISCOMFORT (mild discomfort), INSOMNIA (insomnia) and FATIGUE (fatigue) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided.      Reporter did not allow further contact
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Neck pain, Pain in extremity, Paraesthesia
Clinical narrative: Hand finger numbness and tingling; Hand finger numbness and tingling; Sore arm; Pain in neck; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Hand finger numbness and tingling ), PARAESTHESIA (Hand finger numbness and tingling), PAIN IN EXTREMITY (Sore arm ) and NECK PAIN (Pain in neck ) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024m20a) for COVID-19 vaccination.     The patient's past medical history included Numbness in hand (the past she has had left hand numbness, but it was associated with chest pain).    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced HYPOAESTHESIA (Hand finger numbness and tingling ), PARAESTHESIA (Hand finger numbness and tingling), PAIN IN EXTREMITY (Sore arm ) and NECK PAIN (Pain in neck ). At the time of the report, HYPOAESTHESIA (Hand finger numbness and tingling ), PARAESTHESIA (Hand finger numbness and tingling), PAIN IN EXTREMITY (Sore arm ) and NECK PAIN (Pain in neck ) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Wrong technique in device usage process
Clinical narrative: shot administered from syringe at 8 hour mark; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG TECHNIQUE IN DEVICE USAGE PROCESS (shot administered from syringe at 8 hour mark) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced WRONG TECHNIQUE IN DEVICE USAGE PROCESS (shot administered from syringe at 8 hour mark). At the time of the report, WRONG TECHNIQUE IN DEVICE USAGE PROCESS (shot administered from syringe at 8 hour mark) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  No treatment details are provided.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: recieved Moderna COVID-19 Vaccine while pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (recieved Moderna COVID-19 Vaccine while pregnant) in a 33-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 13-Sep-2021. On 02-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (recieved Moderna COVID-19 Vaccine while pregnant). On 02-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (recieved Moderna COVID-19 Vaccine while pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided by the reporter.  No treatment information was provided by the reporter.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Left nostril is running like a faucet) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. Concurrent medical conditions included Seasonal allergy. Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Seasonal allergy. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced RHINORRHOEA (Left nostril is running like a faucet). At the time of the report, RHINORRHOEA (Left nostril is running like a faucet) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was reported. Reporter did not allow further contact.
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: gave 17 year old vaccine; A sontaneous report was received from a health care professional concerning a 17-year-old, female patient who received Moderna's COVID-19 Vaccine (mRNA-1273).    The patient's medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event,was not provided.   On unknown date , prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (Lot unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   Action taken with mRNA-1273 in response to the event was not reported.   The outcome of the event, was considered as recovered.; Reporter's Comments: This report refers to a case of product administered to patient of inappropriate age (17 year old) for mRNA-1273 (lot number unknown) with no associated AEs reported.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect route of product administration, Vaccination site pain
Clinical narrative: Incorrect route of product administration; Vaccination site pain; This spontaneous case was reported by a physician and describes the occurrence of INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Incorrect route of product administration ) and VACCINATION SITE PAIN (Vaccination site pain) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 032L20A) for COVID-19 vaccination.     The patient's past medical history included Major depression on 01-Jan-1980. Concurrent medical conditions included Drug allergy (CA++ Channel Blockers), Asthma since 01-Jan-1950, Type 2 diabetes mellitus since 01-Jan-2000 and Arthritis (gradually worse with age) since 01-Jan-2006. Concomitant products included FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) from 01-Jan-2010 to an unknown date for Asthma, CITALOPRAM from 01-Jan-1987 to an unknown date for Depression, METFORMIN from 01-Jan-2010 to an unknown date, GLIMEPIRIDE from 01-Jan-2015 to an unknown date and INSULIN HUMAN INJECTION, ISOPHANE (NOVOLIN N) from 01-Jan-2010 to an unknown date for Diabetes.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Incorrect route of product administration ) and VACCINATION SITE PAIN (Vaccination site pain). On 01-Mar-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Incorrect route of product administration ) had resolved. At the time of the report, VACCINATION SITE PAIN (Vaccination site pain) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous), the reporter did not provide any causality assessments.   No treatment medication were provided. Action taken for Moderna COVID-19 Vaccine was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-031651, US-MODERNATX, INC.-MOD-2021-032479 (E2B Linked Report). This case was linked to MOD-2021-031572 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 31-Mar-2021: Historical condition and concomitant products were added.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, vaccination site pain, a causal relationship cannot be excluded. This report also refers to a case of incorrect route of product administration for mRNA-1273, lot # 014M20A   with no associated AEs. US-MODERNATX, INC.-MOD-2021-031651:Crosslinked case: Same reporter (Wife case 1st dose) US-MODERNATX, INC.-MOD-2021-032479:Crosslinked case: Same reporter (Wife case (2nd dose)
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Peripheral swelling, Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Armpit is swollen; Armpit is hurting; Redness at the injection; Arm swell up the size of a silver dollar at the injection/swelling about 6 inches in diameter; Hotness,warmth at the injection; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Armpit is swollen), VACCINATION SITE WARMTH (Hotness,warmth at the injection), AXILLARY PAIN (Armpit is hurting), VACCINATION SITE ERYTHEMA (Redness at the injection) and VACCINATION SITE SWELLING (Arm swell up the size of a silver dollar at the injection/swelling about 6 inches in diameter) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Hotness,warmth at the injection), VACCINATION SITE ERYTHEMA (Redness at the injection) and VACCINATION SITE SWELLING (Arm swell up the size of a silver dollar at the injection/swelling about 6 inches in diameter). On 01-Mar-2021, the patient experienced PERIPHERAL SWELLING (Armpit is swollen) and AXILLARY PAIN (Armpit is hurting). At the time of the report, PERIPHERAL SWELLING (Armpit is swollen), VACCINATION SITE WARMTH (Hotness,warmth at the injection), AXILLARY PAIN (Armpit is hurting) and VACCINATION SITE ERYTHEMA (Redness at the injection) outcome was unknown and VACCINATION SITE SWELLING (Arm swell up the size of a silver dollar at the injection/swelling about 6 inches in diameter) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.  No treatment information was reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Skin discolouration, Swelling
Clinical narrative: bump the size of silver dollar; itching; arm was pink; This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISCOLOURATION (arm was pink), SWELLING (bump the size of silver dollar) and PRURITUS (itching) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE and PRAMOXINE for an unknown indication.    On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced SKIN DISCOLOURATION (arm was pink). On 10-Feb-2021, the patient experienced SWELLING (bump the size of silver dollar) and PRURITUS (itching). At the time of the report, SKIN DISCOLOURATION (arm was pink), SWELLING (bump the size of silver dollar) and PRURITUS (itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient also took Allergy meds as concomitant medication The Treatment information was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: Arm was very painful and really puffed out; Arm was very painful and really puffed out; This spontaneous case was reported by an other and describes the occurrence of PAIN IN EXTREMITY (Arm was very painful and really puffed out) and PERIPHERAL SWELLING (Arm was very painful and really puffed out) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm was very painful and really puffed out) and PERIPHERAL SWELLING (Arm was very painful and really puffed out). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event following immunisation, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm was very painful and really puffed out) and PERIPHERAL SWELLING (Arm was very painful and really puffed out) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Information was obtained from a pharmaceutical company which was reported to them by a consumer.  The consumer's son received the first dose of the Moderna vaccine.   No relevant concomitant medications were reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Hyperhidrosis, Night sweats, Pyrexia
Clinical narrative: sweating; night sweats; fever; chills/shivering at night; headaches; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating), NIGHT SWEATS (night sweats), PYREXIA (fever), CHILLS (chills/shivering at night) and HEADACHE (headaches) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 immunization.     Concomitant products included MONTELUKAST SODIUM (SINGULAIR), SALBUTAMOL (VENTOLINE [SALBUTAMOL]), FLUTICASONE PROPIONATE (FLOVENT), LOVASTATIN, LOSARTAN, HCTZ and ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced HYPERHIDROSIS (sweating), NIGHT SWEATS (night sweats), PYREXIA (fever), CHILLS (chills/shivering at night) and HEADACHE (headaches). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 2 dosage form every six hours. On 22-Feb-2021, HYPERHIDROSIS (sweating), NIGHT SWEATS (night sweats), PYREXIA (fever), CHILLS (chills/shivering at night) and HEADACHE (headaches) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Headache, Urinary incontinence, Vaccination complication, Vaccination site induration
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (So weak. could not get up), URINARY INCONTINENCE (pea in her pants), VACCINATION COMPLICATION (had a reaction), VACCINATION SITE INDURATION (it was hard to the touch) and HEADACHE (excruciating headache) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced ASTHENIA (So weak. could not get up), URINARY INCONTINENCE (pea in her pants), VACCINATION COMPLICATION (had a reaction), VACCINATION SITE INDURATION (it was hard to the touch), HEADACHE (excruciating headache) and VACCINATION SITE PAIN (Injection Site hurt). The patient was treated with HYDROCODONE on 19-Feb-2021 for Adverse event following immunisation, at a dose of 1 dosage form. In February 2021, ASTHENIA (So weak. could not get up) had resolved. On 21-Feb-2021, URINARY INCONTINENCE (pea in her pants), VACCINATION COMPLICATION (had a reaction), VACCINATION SITE INDURATION (it was hard to the touch), HEADACHE (excruciating headache) and VACCINATION SITE PAIN (Injection Site hurt) had resolved.            No relevant concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Significant follow-up Telephone Contact Report received and event outcomes updated to recovered since the patient stated she was fine.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (So weak. could not get up), URINARY INCONTINENCE (pea in her pants), VACCINATION COMPLICATION (had a reaction), VACCINATION SITE INDURATION (it was hard to the touch) and HEADACHE (excruciating headache) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced ASTHENIA (So weak. could not get up), URINARY INCONTINENCE (pea in her pants), VACCINATION COMPLICATION (had a reaction), VACCINATION SITE INDURATION (it was hard to the touch), HEADACHE (excruciating headache) and VACCINATION SITE PAIN (Injection Site hurt). The patient was treated with HYDROCODONE on 19-Feb-2021 for Adverse event following immunisation, at a dose of 1 dosage form. In February 2021, ASTHENIA (So weak. could not get up) had resolved. On 21-Feb-2021, URINARY INCONTINENCE (pea in her pants), VACCINATION COMPLICATION (had a reaction), VACCINATION SITE INDURATION (it was hard to the touch), HEADACHE (excruciating headache) and VACCINATION SITE PAIN (Injection Site hurt) had resolved.            No relevant concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Significant follow-up Telephone Contact Report received and event outcomes updated to recovered since the patient stated she was fine.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received the vaccine outside of temperature range; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received the vaccine outside of temperature range) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received the vaccine outside of temperature range). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received the vaccine outside of temperature range) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  It was reported that 10 people received the vaccine that were outside of the temperature range.  No treatment information was provided.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: Pregnant while receiving the vaccine; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant while receiving the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant while receiving the vaccine). At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant while receiving the vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was provided. No treatment medication information was provided.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Injection site discolouration, Injection site pain, Injection site swelling, Lymphadenopathy
Clinical narrative: lymph nodes along the left neck swollen.; lymph nodes along the left side of back swollen/lymph nodes along the left ear swollen; lymph nodes along the left collarbone swollen; Covid arm; pinkish spot at the injection site; Mild itching at the injection site; mild swelling at the injection site; soreness at the injection site; muscle pain; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of TYPE IV HYPERSENSITIVITY REACTION (Covid arm), INJECTION SITE DISCOLOURATION (pinkish spot at the injection site), PRURITUS (Mild itching at the injection site), SWELLING (lymph nodes along the left neck swollen.) and SWELLING (lymph nodes along the left side of back swollen/lymph nodes along the left ear swollen) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced INJECTION SITE DISCOLOURATION (pinkish spot at the injection site), PRURITUS (Mild itching at the injection site), INJECTION SITE SWELLING (mild swelling at the injection site), INJECTION SITE PAIN (soreness at the injection site), MYALGIA (muscle pain) and ARTHRALGIA (joint pain). On 27-Feb-2021, the patient experienced TYPE IV HYPERSENSITIVITY REACTION (Covid arm), SWELLING (lymph nodes along the left neck swollen.), SWELLING (lymph nodes along the left side of back swollen/lymph nodes along the left ear swollen) and LYMPHADENOPATHY (lymph nodes along the left collarbone swollen). At the time of the report, TYPE IV HYPERSENSITIVITY REACTION (Covid arm), INJECTION SITE DISCOLOURATION (pinkish spot at the injection site), PRURITUS (Mild itching at the injection site), SWELLING (lymph nodes along the left neck swollen.), SWELLING (lymph nodes along the left side of back swollen/lymph nodes along the left ear swollen), LYMPHADENOPATHY (lymph nodes along the left collarbone swollen), INJECTION SITE SWELLING (mild swelling at the injection site), INJECTION SITE PAIN (soreness at the injection site), MYALGIA (muscle pain) and ARTHRALGIA (joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.  Treatment included Benadryl cream, oral Benadryl.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Non-significant follow-up received on 20-jul-2021- Email details were updated.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pruritus, Swelling, Type IV hypersensitivity reaction
Clinical narrative: lymph nodes along the left neck swollen.; lymph nodes along the left side of back swollen/lymph nodes along the left ear swollen; lymph nodes along the left collarbone swollen; Covid arm; pinkish spot at the injection site; Mild itching at the injection site; mild swelling at the injection site; soreness at the injection site; muscle pain; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of TYPE IV HYPERSENSITIVITY REACTION (Covid arm), INJECTION SITE DISCOLOURATION (pinkish spot at the injection site), PRURITUS (Mild itching at the injection site), SWELLING (lymph nodes along the left neck swollen.) and SWELLING (lymph nodes along the left side of back swollen/lymph nodes along the left ear swollen) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced INJECTION SITE DISCOLOURATION (pinkish spot at the injection site), PRURITUS (Mild itching at the injection site), INJECTION SITE SWELLING (mild swelling at the injection site), INJECTION SITE PAIN (soreness at the injection site), MYALGIA (muscle pain) and ARTHRALGIA (joint pain). On 27-Feb-2021, the patient experienced TYPE IV HYPERSENSITIVITY REACTION (Covid arm), SWELLING (lymph nodes along the left neck swollen.), SWELLING (lymph nodes along the left side of back swollen/lymph nodes along the left ear swollen) and LYMPHADENOPATHY (lymph nodes along the left collarbone swollen). At the time of the report, TYPE IV HYPERSENSITIVITY REACTION (Covid arm), INJECTION SITE DISCOLOURATION (pinkish spot at the injection site), PRURITUS (Mild itching at the injection site), SWELLING (lymph nodes along the left neck swollen.), SWELLING (lymph nodes along the left side of back swollen/lymph nodes along the left ear swollen), LYMPHADENOPATHY (lymph nodes along the left collarbone swollen), INJECTION SITE SWELLING (mild swelling at the injection site), INJECTION SITE PAIN (soreness at the injection site), MYALGIA (muscle pain) and ARTHRALGIA (joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.  Treatment included Benadryl cream, oral Benadryl.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Non-significant follow-up received on 20-jul-2021- Email details were updated.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Feeling abnormal, Feeling hot, Headache
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Head feels hot), PRURITUS (itching on hands, itching on rib cages), ASTHENIA (Overall weakness), PAIN IN EXTREMITY (left arm is sore) and LIMB MASS (little painful lumps all over forearm and tender spots - on forearm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Family history included Drug allergy (paradoxical drug). Concurrent medical conditions included Drug allergy (seasonal allergies).    On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING HOT (Head feels hot), PRURITUS (itching on hands, itching on rib cages), ASTHENIA (Overall weakness), PAIN IN EXTREMITY (left arm is sore), LIMB MASS (little painful lumps all over forearm and tender spots - on forearm), PAIN (little painful lumps all over forearm and tender spots - on forearm), SWELLING (swelling on cheeks, swelling a little bit on eyes and glands on throat are swollen), HEADACHE (Headache), ASTHENIA (Weak kneed), ARTHRALGIA (Pain in shoulders), PAIN (Achiness) and FEELING ABNORMAL (Fuzziness in my thing). At the time of the report, FEELING HOT (Head feels hot), PRURITUS (itching on hands, itching on rib cages), ASTHENIA (Overall weakness), PAIN IN EXTREMITY (left arm is sore), LIMB MASS (little painful lumps all over forearm and tender spots - on forearm), PAIN (little painful lumps all over forearm and tender spots - on forearm), SWELLING (swelling on cheeks, swelling a little bit on eyes and glands on throat are swollen), HEADACHE (Headache), ASTHENIA (Weak kneed), ARTHRALGIA (Pain in shoulders), PAIN (Achiness) and FEELING ABNORMAL (Fuzziness in my thing) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. Treatment included Tylenol, Claritin    This case was linked to MOD-2021-032621 (Patient Link).
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Limb mass, Pain, Pain in extremity, Pruritus, Swelling
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Head feels hot), PRURITUS (itching on hands, itching on rib cages), ASTHENIA (Overall weakness), PAIN IN EXTREMITY (left arm is sore) and LIMB MASS (little painful lumps all over forearm and tender spots - on forearm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Family history included Drug allergy (paradoxical drug). Concurrent medical conditions included Drug allergy (seasonal allergies).    On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING HOT (Head feels hot), PRURITUS (itching on hands, itching on rib cages), ASTHENIA (Overall weakness), PAIN IN EXTREMITY (left arm is sore), LIMB MASS (little painful lumps all over forearm and tender spots - on forearm), PAIN (little painful lumps all over forearm and tender spots - on forearm), SWELLING (swelling on cheeks, swelling a little bit on eyes and glands on throat are swollen), HEADACHE (Headache), ASTHENIA (Weak kneed), ARTHRALGIA (Pain in shoulders), PAIN (Achiness) and FEELING ABNORMAL (Fuzziness in my thing). At the time of the report, FEELING HOT (Head feels hot), PRURITUS (itching on hands, itching on rib cages), ASTHENIA (Overall weakness), PAIN IN EXTREMITY (left arm is sore), LIMB MASS (little painful lumps all over forearm and tender spots - on forearm), PAIN (little painful lumps all over forearm and tender spots - on forearm), SWELLING (swelling on cheeks, swelling a little bit on eyes and glands on throat are swollen), HEADACHE (Headache), ASTHENIA (Weak kneed), ARTHRALGIA (Pain in shoulders), PAIN (Achiness) and FEELING ABNORMAL (Fuzziness in my thing) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. Treatment included Tylenol, Claritin    This case was linked to MOD-2021-032621 (Patient Link).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Arthritis, Bladder pain
Clinical narrative: Pain in whole body in the same places she has arthritis after 1st dose/Patient had arthritis in her body everywhere; Bladder burn after 1st shot; This spontaneous case was reported by a consumer and describes the occurrence of BLADDER PAIN (Bladder burn after 1st shot) and ARTHRITIS (Pain in whole body in the same places she has arthritis after 1st dose/Patient had arthritis in her body everywhere) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031mzua) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis. Concomitant products included RIVAROXABAN (XARELTO), DILTIAZEM, AMLODIPINE, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and BIOTIN for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced BLADDER PAIN (Bladder burn after 1st shot). On 24-Feb-2021, the patient experienced ARTHRITIS (Pain in whole body in the same places she has arthritis after 1st dose/Patient had arthritis in her body everywhere). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 28-Feb-2021, BLADDER PAIN (Bladder burn after 1st shot) and ARTHRITIS (Pain in whole body in the same places she has arthritis after 1st dose/Patient had arthritis in her body everywhere) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient took Tylenol for the pain. Antibiotic was also used as treatment medication.   Most recent FOLLOW-UP information incorporated above includes: On 06-Apr-2021: Follow up received on 06-APR-2021.Significant follow up appended.Event verbatim term was updated(Pain in whole body in the same places as she has arthritis after 1st dose was changed to Patient had arthritis in her body every where).An additional contact number is also included.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster, Neuralgia, Vaccination complication
Clinical narrative: Severe reaction; pretty svere nerve pain; Shingles; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Severe reaction), HERPES ZOSTER (Shingles) and NEURALGIA (pretty svere nerve pain) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013D720A) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, the patient experienced HERPES ZOSTER (Shingles). On an unknown date, the patient experienced VACCINATION COMPLICATION (Severe reaction) and NEURALGIA (pretty svere nerve pain). At the time of the report, VACCINATION COMPLICATION (Severe reaction), HERPES ZOSTER (Shingles) and NEURALGIA (pretty svere nerve pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       the concomitant product is not provided Treatment included Valacyclovir